Zobrazeno 1 - 10
of 846
pro vyhledávání: '"Alan W. Partin"'
Autor:
Claire Guest, Rob Harris, Karen S Sfanos, Eva Shrestha, Alan W Partin, Bruce Trock, Leslie Mangold, Rebecca Bader, Adam Kozak, Scott Mclean, Jonathan Simons, Howard Soule, Thomas Johnson, Wen-Yee Lee, Qin Gao, Sophie Aziz, Patritsia Maria Stathatou, Stephen Thaler, Simmie Foster, Andreas Mershin
Publikováno v:
PLoS ONE, Vol 16, Iss 2, p e0245530 (2021)
Prostate cancer is the second leading cause of cancer death in men in the developed world. A more sensitive and specific detection strategy for lethal prostate cancer beyond serum prostate specific antigen (PSA) population screening is urgently neede
Externí odkaz:
https://doaj.org/article/1d622d5373d9440f92945dcf1d37975c
Autor:
Eugene Shenderov, Michael A. Gorin, Seohyun Kim, Pamela T. Johnson, Mohamad E. Allaf, Alan W. Partin, Martin G. Pomper, Emmanuel S. Antonarakis, Kenneth J. Pienta, Steven P. Rowe
Publikováno v:
Urology Case Reports, Vol 17, Iss C, Pp 22-25 (2018)
Radiotracers targeting prostate-specific membrane antigen (PSMA), including [18F]DCFPyL, have been extensively investigated as a means to image prostate cancer more accurately. We present the case of a man with oligometastatic prostate cancer who was
Externí odkaz:
https://doaj.org/article/b8507af67bf6401886d6489b255b41b1
Autor:
Bruce J. Trock, Yuezhou Jing, Brent Mabey, Zaina Sangale, Lauren Lenz, Nora Haney, Igor Vidal, Stephanie A. Glavaris, Gunes Guner, Onur Ertunc, Ibrahim Kulac, Javier A. Baena Del Valle, Tracy Jones, Misop Han, Alan W. Partin, Todd Cohen, Steven Stone, Angelo M. De Marzo
Publikováno v:
Journal of Urology. 208:1182-1193
The prognostic value for metastasis of the cell-cycle progression score and phosphatase and tensin homolog haven't been evaluated jointly in contemporary men with exclusively intermediate- or high-risk prostate cancer. We evaluated associations of ce
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bcc380b5ee60f8f28a37f0361fded189
https://doi.org/10.1097/ju.0000000000002922
https://doi.org/10.1097/ju.0000000000002922
Autor:
Robert W. Veltri, H. Ballentine Carter, Alan W. Partin, Jonathan I. Epstein, Cameron Marlow, Patricia Landis, Lori J. Sokoll, Sumit Isharwal, Danil V. Makarov
Purpose: We assessed the association of quantitative clinical and pathologic information, including serum and tissue pro–prostate-specific antigen (proPSA) measurements, with outcomes among men with prostate cancer in an expectant management (activ
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::89f332a853c77e28b4939736bac12eee
https://doi.org/10.1158/1078-0432.c.6517951
https://doi.org/10.1158/1078-0432.c.6517951
Autor:
Angelo M. De Marzo, William B. Isaacs, George J. Netto, Misop Han, Alan W. Partin, Elizabeth Humphreys, Ben H. Park, Jessica L. Hicks, Jianfeng Xu, Wennuan Liu, David Esopi, Siobhan Sutcliffe, Bora Gurel, Tamara L. Lotan
Purpose: Analytically validated assays to interrogate biomarker status in clinical samples are crucial for personalized medicine. PTEN is a tumor suppressor commonly inactivated in prostate cancer that has been mechanistically linked to disease aggre
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7180cfd967d73e6b371dcdef789ab081
https://doi.org/10.1158/1078-0432.c.6519758.v1
https://doi.org/10.1158/1078-0432.c.6519758.v1
Autor:
Michael A. Carducci, Angelo M. De Marzo, Robin Gurganus, Daniel J. George, Phillip G. Febbo, Helen Fedor, Antonio Jimeno, Alan W. Partin, Luciana Schultz, Roula Albadine, Ting Wang, S. Lindsay Davis, Kelly Mundy, Patricia A. Creel, David P. Wood, Susan Halabi, Michelle A. Rudek, George J. Netto, Andrew J. Armstrong
Purpose: Given discrepancies between preclinical and clinical observations of mammalian target of rapamycin (mTOR) inhibition in prostate cancer, we sought to determine the pharmacodynamic effects of the mTOR/TORC1 inhibitor rapamycin in men with int
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7d89e2c593bd06ba355c5eb1dd80c5a7
https://doi.org/10.1158/1078-0432.c.6519354
https://doi.org/10.1158/1078-0432.c.6519354
Autor:
Charles G. Drake, Emmanuel S. Antonarakis, Angelo M. De Marzo, Onur Ertunc, Javier A. Baena-Del Valle, Gunes Guner, Jennifer N. Durham, Haiyi Cao, Tanya O'Neal, Carolyn G. Chapman, David Liu, Thomas R. Nirschl, Mohamad E. Allaf, Ashley E. Ross, Edward M. Schaeffer, Alan W. Partin, Marianna L. Zahurak, Matthew C. Dallos, Aleksandar Z. Obradovic
Purpose:Previous studies suggest that androgen deprivation therapy (ADT) promotes antitumor immunity in prostate cancer. Whether a vaccine-based approach can augment this effect remains unknown.Patients and Methods:We conducted a neoadjuvant, randomi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::557358a888355ec5c7040ca5dd45ac05
https://doi.org/10.1158/1078-0432.c.6529697.v1
https://doi.org/10.1158/1078-0432.c.6529697.v1
Autor:
Angelo M. De Marzo, William B. Isaacs, George J. Netto, Misop Han, Alan W. Partin, Elizabeth Humphreys, Ben H. Park, Jessica L. Hicks, Jianfeng Xu, Wennuan Liu, David Esopi, Siobhan Sutcliffe, Bora Gurel, Tamara L. Lotan
PDF file - 69KB, Correlation of PTEN protein status by immunohistochemistry (IHC) with PTEN genomic status by sequencing in NCI-60 cell line panel.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5488de7a0a9d0e380a4aed9400cf5c91
https://doi.org/10.1158/1078-0432.22443293
https://doi.org/10.1158/1078-0432.22443293
Autor:
Charles G. Drake, Emmanuel S. Antonarakis, Angelo M. De Marzo, Onur Ertunc, Javier A. Baena-Del Valle, Gunes Guner, Jennifer N. Durham, Haiyi Cao, Tanya O'Neal, Carolyn G. Chapman, David Liu, Thomas R. Nirschl, Mohamad E. Allaf, Ashley E. Ross, Edward M. Schaeffer, Alan W. Partin, Marianna L. Zahurak, Matthew C. Dallos, Aleksandar Z. Obradovic
Figure S2
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a95774f5f71ae1459ca3038756641aab
https://doi.org/10.1158/1078-0432.22477550
https://doi.org/10.1158/1078-0432.22477550
Autor:
Michael A. Carducci, Angelo M. De Marzo, Robin Gurganus, Daniel J. George, Phillip G. Febbo, Helen Fedor, Antonio Jimeno, Alan W. Partin, Luciana Schultz, Roula Albadine, Ting Wang, S. Lindsay Davis, Kelly Mundy, Patricia A. Creel, David P. Wood, Susan Halabi, Michelle A. Rudek, George J. Netto, Andrew J. Armstrong
Supplementary Data from A Pharmacodynamic Study of Rapamycin in Men with Intermediate- to High-Risk Localized Prostate Cancer
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1b5a4fa2460be48a93fb41a6b517b0c3
https://doi.org/10.1158/1078-0432.22442682.v1
https://doi.org/10.1158/1078-0432.22442682.v1